Investor Notification: Bronstein, Gewirtz & Grossman LLC Declares Opportunity for Significant Loss Sufferers of XPLR Infrastructure, LP to Initiate Class Action Lawsuit
In a recent development, a class action lawsuit has been filed against XPLR Infrastructure, LP (XIFR) and certain of its officers. The lawsuit, which seeks to recover damages against the defendants, alleges that they made false and/or misleading statements and failed to disclose several issues related to XPLR's operations and financings.
The defendants' public statements were materially false and misleading at all relevant times, according to the complaint. The lawsuit specifically points to the unsustainable yieldco business model and distribution growth rate of XPLR as areas of concern.
As a result, defendants planned to halt cash distributions to investors and instead redirect those funds to resolve certain financings. This move was intended to temporarily relieve the issue, but the complaint alleges that defendants downplayed the attendant risks.
XPLR could not resolve those financings before their maturity date without risking significant unitholder dilution, the complaint further states.
The class action lawsuit seeks to recover damages on behalf of all persons who purchased or otherwise acquired XPLR securities between September 27, 2023, and January 27, 2025. If you fall under this category and wish to be a part of the lawsuit, you have until September 8, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC, the firm handling the lawsuit, is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide.
The contact person for information regarding the lawsuit is Eric J. Grossman, the Client Liaison Manager at Bronstein, Gewirtz & Grossman, LLC. The firm can be contacted at Peretz Bronstein or Nathan Miller, 332-239-2660, or [email protected].
For updates on the lawsuit, you can follow Bronstein, Gewirtz & Grossman, LLC on LinkedIn, Facebook, or Instagram. It is important to note that prior results do not guarantee similar outcomes. This is attorney advertising.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Trump's Policies: Tariffs, AI, Surveillance, and Possible Martial Law
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
